Artemis Medicare Services Ltd.

NSE: ARTEMISMED · Hospital

—
52W Range₹203 – ₹379

Snapshot

Unlock Artemis Medicare Services Ltd.'s vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

Artemis Medicare Services Limited operates multi-specialty hospitals providing a comprehensive range of medical, surgical, and inpatient and outpatient services. The company is primarily anchored by its flagship 541-bed facility located in Gurugram, India.

Business Model

The company generates revenue through the provision of healthcare services, including diagnostic, surgical, and therapeutic interventions within its hospital facilities. It operates on a fee-for-service model catering to both domestic and international patients.

  • Hospital Bed Capacity:541

Growth Outlook

Growth is driven by the expansion of medical service offerings and the continued operational scaling of its multi-specialty hospital infrastructure in Gurugram.

Key Risks

  • Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
  • Operational Risk. The company faces significant challenges in maintaining high-quality medical standards and retaining skilled healthcare professionals.
  • Competitive Risk. The hospital sector in India is highly fragmented and competitive, with increasing pressure from both established players and new entrants.
  • Infrastructure Dependency. Reliance on a concentrated asset base in Gurugram exposes the company to localized economic or operational disruptions.

Start your research today

Unlock AI insights, financials, peers and live data on Artemis Medicare Services Ltd. and 5,000+ companies — free.

Start your research

Key Metrics

REVENUE

₹1,150 Cr

TTM · consolidated

+14.8%YoY

NET PROFIT

₹115 Cr

TTM · consolidated

+21.5%YoY

EPS

₹7.25

TTM · consolidated

+20.0%YoY

RETURN ON EQUITY

12.3%

TTM · consolidated

+1.6 ppYoY

RETURN ON CAPITAL EMPLOYED

14.4%

TTM · consolidated

+1.2 ppYoY

P/E

39.1×

Q2 FY27 · consolidated

39.1 vs 65.8x5Y avg

EV/EBITDA

20.6x

Q2 FY27 · consolidated

20.6 vs 38.2x5Y avg

EBITDA MARGIN

20.5%

TTM · consolidated

+0.4 ppYoY

NET PROFIT MARGIN

10.0%

Q2 FY27 · consolidated

-0.9 ppYoY

DEBT TO EQUITY

0.2x

Q2 FY27 · consolidated

-0.03xYoY

Peers · Hospital

CompanyMkt CapP/E (TTM)EV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
Artemis Medicare Services Ltd.ARTEMISMED
₹4,642 Cr39.1×20.6014.8%20.5%12.3%14.4%+14.6%
Kovai Medical Center & Hospital LimitedKOVAI
₹6,364 Cr25.1×13.7015.0%29.6%21.3%22.7%-8.2%
Indraprastha Medical Corporation Ltd.INDRAMEDCO
₹2,802 Cr15.1×9.2110.9%19.9%28.1%34.6%-48.8%
Dr Agarwals Eye Hospital LimitedDRAGARWQ
₹2,570 Cr34.1×16.7020.0%31.9%27.4%18.9%+3.4%
K M C Speciality Hospitals (India) LimitedKMCSHIL
₹2,420 Cr42.3×23.0235.1%32.0%29.8%31.1%+110.0%
Shalby Ltd.SHALBY
₹1,303 Cr34.4×10.716.5%14.5%3.8%7.8%-50.1%

As of Q2 FY27

Financials